| Current Price | $0.41 | Mkt Cap | $49.0M |
|---|---|---|---|
| Open | $0.41 | P/E Ratio | -0.56 |
| Prev. Close | $0.41 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.37 - $0.42 | Volume | 604,647 |
| 52-Wk Range | $0.28 - $1.45 | Avg. Daily Vol. | 875,684 |
| Current Price | $0.41 | Mkt Cap | $49.0M |
|---|---|---|---|
| Open | $0.41 | P/E Ratio | -0.56 |
| Prev. Close | $0.41 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.37 - $0.42 | Volume | 604,647 |
| 52-Wk Range | $0.28 - $1.45 | Avg. Daily Vol. | 875,684 |
The best Bull and Bear pitches based on recency and number of recommendations.
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about DTIL.
Recs
offerbk1
(< 20)
Submitted: 2/21/2021 12:58:54 PM :
Start Price:
$12.05
NASDAQ:DTIL Score:
-115.03
Gene Editing is at its start. DTIL has patents and a system that is more efficient than CRSP/NTLA/EDIT which is based on tech that won Nobel Prize. Moreover the MktCap of these 3 shows us that DTIL is undervalued due to the fact it is less known and promoted. While there is still no product DTIL already has big pharma lining up for partnership and also a business for agriculture. The future seems very bright for DTIL and as the products trials and eventually products will be released I beleive DTIL could be anywhere between 10x and 100x in the next 5 years.
Recs
MattK520
(< 20)
Submitted: 3/28/2019 11:30:05 AM :
Start Price:
$18.00
NASDAQ:DTIL Score:
-161.20
Revolutionary gene editing technology, alternative to CRISPR
Find the members with the highest scoring picks in DTIL.
TheFall2021 (93.39) Score: +116.13
The Score Leader is the player with the highest score across all their picks in DTIL.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| TheFall2021 | 93.39 | 1/21/2021 |
|
5Y | $13.71 | -97.05% | +19.09% | +116.13 | 0 Comment | |
| GabrielSevrs | < 20 | 6/8/2021 |
|
3W | $11.60 | -96.51% | +8.45% | +104.96 | 0 Comment | |
| sikiliza | < 20 | 7/28/2021 |
|
5Y | $9.77 | -95.85% | +4.22% | +100.07 | 0 Comment | |
| wsmoot8796 | 77.59 | 6/9/2022 |
|
1Y | $1.76 | -76.99% | +11.94% | +88.93 | 0 Comment | |
| Playa17 | < 20 | 11/17/2022 |
|
5Y | $1.53 | -73.53% | +17.36% | -90.89 | 0 Comment | |
| MattMarlatt | < 20 | 4/29/2021 |
|
5Y | $9.57 | -95.77% | +9.10% | -104.87 | 0 Comment | |
| TruffelPig | < 20 | 5/11/2021 |
|
5Y | $7.85 | -94.84% | +10.92% | -105.77 | 0 Comment | |
| GrapeFool | < 20 | 2/19/2021 |
|
5Y | $11.46 | -96.47% | +16.87% | -113.34 | 0 Comment | |
| kefuerst | < 20 | 2/22/2021 |
|
5Y | $12.05 | -96.64% | +18.39% | -115.03 | 0 Comment | |
| offerbk1 | < 20 | 2/22/2021 |
|
5Y | $12.05 | -96.64% | +18.39% | -115.03 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
